ストックスクリーナーアプリを入手
0.611
15.07%
0.08
アフターアワーズ：
.65
0.039
+6.38%
Nexgel Inc (NXGL) 最新ニュース
Nexgel CEO Adam Levy sells $1,840 in shares - Investing.com
NEXGEL (NXGL) CEO sells 3,000 shares, retains 333,692-holding stake - Stock Titan
Nexgel CEO Adam Levy sells $3,421 of common stock By Investing.com - Investing.com Nigeria
Nexgel CEO Adam Levy sells $3,421 of common stock - Investing.com
NEXGEL (NXGL) CEO Adam Levy sells 6,000 common shares but keeps large stake - Stock Titan
Large potential dilution as NexGel (NASDAQ: NXGL) seeks note conversion, Nevada move and reverse split - Stock Titan
NEXGEL Expands Investor Outreach With MicroCap Conference Appearance - MyChesCo
NXGL Q1 2026 Earnings: EPS Misses Estimates by 54% Despite Positive Stock ReactionProfitability Analysis - newsline.com
NexGel Inc Warrant (NXGLW) Slides Marginally, Testing Key Support at $0.04Volume Nodes - newsline.com
NexGel stock (US65340W1027): Micro-cap hydrogel specialist in focus after recent volatility - AD HOC NEWS
NexGel Inc (NXGL) Weakens by 4.43% as Shares Approach Critical $0.53 Support LevelNHNL Divergence - newsline.com
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th - GlobeNewswire
NEXGEL heads to Las Vegas for Planet MicroCap 2026 conference - Stock Titan
Nexgel CEO Adam Levy sells $1,171 in company stock - Investing.com UK
Nexgel CEO Adam Levy sells $1,171 in company stock By Investing.com - Investing.com Australia
NXGL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NEXGEL (NXGL) CEO Adam R. Levy sells 2,000 common shares at $0.5859 - Stock Titan
New Celularity (NASDAQ: CELU) CCO to drive cenplacel-L and Lifebank growth - Stock Titan
Celularity outlines placenta cell therapy push to extend health span - Stock Titan
NXGL Q1 2026 Earnings: EPS Misses Estimates as Company Faces Operational HeadwindsAdjusted Earnings Analysis - newsline.com
Number of shareholders of NexGel, Inc – BOATS:NXGL - TradingView
symbol__ Stock Quote Price and Forecast - CNN
NexGel Inc stock (US65340W1027): shares hover near 52-week lows as investors await fresh catalysts - AD HOC NEWS
Nexgel CEO Adam Levy sells 13,000 shares for $7,834 By Investing.com - Investing.com India
NexGel Inc Warrant (NXGLW) Remains Flat at $0.05 as Traders Await CatalystProfit Surge Picks - newsline.com
Nexgel CEO Adam Levy sells 13,000 shares for $7,834 - Investing.com UK
NEXGEL (NASDAQ: NXGL) CEO Adam R. Levy sells 13,000 shares in open market trades - Stock Titan
NexGel Inc (NXGL) Holds Near Support After Marginal DeclineLarge Cap Trends - thelegaladvocate.com
NexGel Inc (NXGL) Hovers Near Support Amid Minimal Price MovementBlock Trade Flow - newsline.com
NexGel (NXGL) asks shareholders to clear potential >19.99% dilution from convertibles - Stock Titan
NXGL Q1 2026 Earnings: EPS Misses Estimates by 54%, Stock DeclinesGuidance Update - newsline.com
NXGL Q1 2026 Earnings: EPS Misses Estimates by Wide Margin Amid Operational ChallengesEarnings Risk Report - thelegaladvocate.com
NXGL Q1 2026 Earnings: Larger-Than-Expected Loss Weighs on SharesDiluted EPS Report - The Legal Advocate
NexGel Inc (NXGL) Slips Slightly as Price Nears Key Support ZoneStatistical Arbitrage - newsline.com
[144] NEXGEL, INC. SEC Filing - Stock Titan
NexGel Inc stock (US65340W1027): hydrogel specialist with micro-cap profile on Nasdaq - AD HOC NEWS
NexGel Inc Warrant (NXGLW) Holds at $0.05 After Slight Decline – Tight Range Signals CautionSuperTrend - The Legal Advocate
NEXGEL Study Targets Safety Risks in Laser Hair Removal - MyChesCo
NexGel Inc (NXGL) Q1 2026 Earnings: EPS Miss on Higher Operating CostsDownward Estimate Revision - newsline.com
NexGel Inc (NXGL) Q1 2026 Earnings: EPS Misses Estimates as Losses WidenShort-Term Outlook - Newser
Langhorne’s Nexgel transforms near disaster into ‘three-team trade’ acquisition - MSN
NexGel Inc (NXGL) Shows Modest Gains, Trading Near Support LevelsOBV Breakout - Newser
NEXGEL Hires Medtech Executive to Expand Surgical Unit - MyChesCo
NexGel Inc (NXGL) Edges Higher as Stock Tests Key Resistance LevelTrade Entry Signals - newsline.com
NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan
NexGel Warrants Trade at $0.06 with No Movement – Key Levels Remain UntestedDiamond Pattern - newsline.com
Maxim Group Maintains NexGel(NXGL.US) With Buy Rating, Maintains Target Price $2 - Moomoo
NexGel Inc stock (US65340W1027): clinical laser study puts hydrogel specialist in focus - AD HOC NEWS
NXGL Should I Buy - Intellectia AI
NexGel Inc (NXGLW) Unchanged at $0.06 — Range-Bound Trading 2026-05-20Rectangle Pattern - The Legal Advocate
Nexgel hydrogel patch reduces laser plume in hair removal study By Investing.com - Investing.com South Africa
Nexgel hydrogel patch reduces laser plume in hair removal study - Investing.com
5.23%
大文字化:
|
ボリューム (24 時間):